Shanghai United Imaging Healthcare Co., Ltd. — Cyborg Score 7/10

Strategic Profile

Founded in 2011 and headquartered in Shanghai, China, the company employs 8,420 people and competes with global medical imaging leaders through domestic manufacturing cost advantages and technological innovation. The company focuses on provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide.

Cyborg Score Rationale

With a market capitalization of $15B and TTM revenue of $1.69B, United Imaging demonstrates substantial scale in the medical device sector. However, recent earnings misses and revenue decline warrant monitoring of execution risks.

Top Insights

• TTM revenue reached $1.69B as of September 2025, reflecting scale in high-margin medical equipment
• 2025 revenue forecast of 4.05B CNY indicates growth trajectory in domestic and international markets
• The company maintains lean operations with approximately 8,170 employees as of December 2025
• Global expansion strategy evident through international sales channels and multi-language product offerings across imaging modalities

Named Competitors

• GE HealthCare — Global leader in medical imaging and diagnostics
• Siemens Healthineers — European leader in medical imaging equipment
• Philips Healthcare — Integrated health technology solutions provider
• Mindray — Chinese medical device manufacturer

Recent Developments

• (April 2025) Released 2024 Annual and Q1 2025 results highlighting strong global expansion and AI innovation
• (April 2025) Released 2024 ESG Report emphasizing sustainable development through innovation
• (February 2026) Stock trading near 126 CNY with market cap around 103.8B CNY reflecting recent market sentiment

Open the full interactive Shanghai United Imaging Healthcare Co., Ltd. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.